Re: Yeh et al.: Ophthalmic Technology Assessment: therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology (Ophthalmology 2015;122:769-78).
Department of Ophthalmology, University "Grigore T. Popa", Iaşi, Romania.
Dan
D
Călugăru
Department of Ophthalmology, University of Medicine Cluj-Napoca, Romania. Electronic address: mihai.calugaru@mail.dntcj.ro.
Mihai
M
Călugăru
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D017075:Laser Coagulation / Q000379:methods*; D008269:Macular Edema / Q000628:therapy*; D012170:Retinal Vein Occlusion / Q000628:therapy*; D013673:Technology Assessment, Biomedical; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D020533:Angiogenesis Inhibitors; D005938:Glucocorticoids; D042461:Vascular Endothelial Growth Factor A